Haplotype analysis confirms association of the serotonin transporter (5‐HTT) gene with schizophrenia but not with major depression

Serotonin (5‐HT) has been implicated in the pathophysiology of several psychiatric disorders including major depressive disorder (MDD) and schizophrenia (SCZ). The serotonin transporter (5‐HTT) is a major regulator of 5‐HT function. 5‐HTT gene polymorphic variants have been associated with both MDD and SCZ. A case–control design was used for candidate gene‐disease association in 194 MDD patients, 155 schizophrenic psychosis patients, and 246 healthy controls, all North European Caucasians. Four polymorphisms were analyzed in terms of genotype, allele, and haplotype‐based associations. Linkage disequilibrium (LD) analysis was also carried out. Bonferroni correction was used for multiple testing. Haplotype‐based analyses showed significant associations between 5‐HTT and SCZ but not MDD. No single locus associations were observed. In agreement with published meta‐analysis our results indicate that 5‐HTT associates with SCZ but not with MDD. It appears that risk for SCZ maps within a specific 5‐HTT haplotype block. © 2007 Wiley‐Liss, Inc.

[1]  M. Rietschel,et al.  The power of sample size and homogenous sampling: Association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder , 2005, Biological Psychiatry.

[2]  P. Zwanzger,et al.  Serotonin-2A-receptor and -transporter polymorphisms: Lack of association in patients with major depression , 2001, European Neuropsychopharmacology.

[3]  N. Martin,et al.  Genetic covariation between neuroticism and the symptoms of anxiety and depression , 1984, Genetic epidemiology.

[4]  H. Meltzer,et al.  Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia , 1996, Brain Research.

[5]  C. Nemeroff,et al.  Neurochemical alterations of serotonergic neuronal systems in depression. , 1992, The Journal of clinical psychiatry.

[6]  M C Neale,et al.  Major depression and generalized anxiety disorder. Same genes, (partly) different environments? , 1992, Archives of general psychiatry.

[7]  C. Benkelfat,et al.  A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior , 2003, Molecular Psychiatry.

[8]  C. Cusin,et al.  Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders. , 2001, Journal of psychiatric research.

[9]  R Judson,et al.  The predictive power of haplotypes in clinical response. , 2000, Pharmacogenomics.

[10]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[11]  J. Kleinman,et al.  Serotonin Uptake Sites and Serotonin Receptors Are Altered in the Limbic System of Schizophrenics , 1993, Neuropsychopharmacology.

[12]  A. Breier.  Serotonin, schizophrenia and antipsychotic drug action , 1995, Schizophrenia Research.

[13]  D. Levinson.  The Genetics of Depression: A Review , 2006, Biological Psychiatry.

[14]  Nitrogen‐containing heteroalicycles with serotonin receptor binding affinity: Development of gastroprokinetic and antiemetic agents , 1999, Medicinal research reviews.

[15]  G. Aghajanian.  Electrophysiological studies on the actions of hallucinogenic drugs at 5-HT2 receptors in rat brain. , 1994, NIDA research monograph.

[16]  I. Melle,et al.  Neurocognitive Dysfunction in First-Episode Psychosis: Correlates With Symptoms, Premorbid Adjustment, and Duration of Untreated Psychosis , 2004 .

[17]  Association between the serotonin transporter gene and affective disorder: The evidence so far , 1997, Molecular medicine.

[18]  M. Åsberg,et al.  Haplotype Analysis Reveals Tryptophan Hydroxylase (TPH) 1 Gene Variants Associated with Major Depression , 2006, Biological Psychiatry.

[19]  K K Kidd,et al.  Population studies of polymorphisms of the serotonin transporter protein gene. , 1999, American journal of medical genetics.

[20]  L. Luthe,et al.  Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets , 1994, Biological Psychiatry.

[21]  M. Rietschel,et al.  Serotonin transporter gene and schizophrenia: evidence for association/linkage disequilibrium in families with affected siblings , 2000, Molecular Psychiatry.

[22]  R. Kahn,et al.  The role of serotonin in schizophrenia. , 1988, Schizophrenia bulletin.

[23]  G. Goodwin,et al.  Polymorphism in serotonin transporter gene associated with susceptibility to major depression , 1996, The Lancet.

[24]  H. Meltzer.  Role of serotonin in the action of atypical antipsychotic drugs. , 1990, Clinical neuroscience.

[25]  Patricia M. Whitaker-Azmitia,et al.  Serotonin and brain development: role in human developmental diseases , 2001, Brain Research Bulletin.

[26]  H. Praag,et al.  The role of serotonin in schizophrenia , 1995, European Neuropsychopharmacology.

[27]  Veena Kumari,et al.  Longitudinal study of symptoms and cognitive function in chronic schizophrenia , 2003, Schizophrenia Research.

[28]  A. Clark,et al.  The role of haplotypes in candidate gene studies , 2004, Genetic epidemiology.

[29]  L. Cardon,et al.  Association study designs for complex diseases , 2001, Nature Reviews Genetics.

[30]  S. Faraone,et al.  Meta‐analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[31]  M. Molliver,et al.  An immunohistochemical study of serotonin neuron development in the rat: Ascending pathways and terminal fields , 1982, Brain Research Bulletin.

[32]  H. Meltzer.  The Role of Serotonin in Antipsychotic Drug Action , 1999, Neuropsychopharmacology.

[33]  I. Lucki,et al.  The spectrum of behaviors influenced by serotonin , 1998, Biological Psychiatry.

[34]  C. Nemeroff,et al.  Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. , 1994, Clinical chemistry.

[35]  B. Pollock,et al.  Polymorphism of the Serotonin Transporter , 2001 .

[36]  J. Joyce,et al.  Alterations in the cortical serotonergic system in schizophrenia: A postmortem study , 1997, Biological Psychiatry.

[37]  S. Mineka,et al.  Comorbidity of anxiety and unipolar mood disorders. , 1998, Annual review of psychology.

[38]  J. Lieberman,et al.  Serotonergic basis of antipsychotic drug effects in schizophrenia , 1998, Biological Psychiatry.

[39]  M. Rietschel,et al.  Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study , 2004, European Journal of Human Genetics.

[40]  P. Sklar,et al.  Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia , 2005, Molecular Psychiatry.

[41]  M. Nöthen,et al.  Search for association between suicide attempt and serotonergic polymorphisms , 2000, Psychiatric genetics.

[42]  J. Quinn,et al.  A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[43]  N. Norton,et al.  Association between a promoter variant in the monoamine oxidase A gene and schizophrenia , 2003, Schizophrenia Research.

[44]  R. Busch,et al.  A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety , 2004, Molecular Psychiatry.

[45]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[46]  M Davies,et al.  The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. , 1992 .

[47]  K. Lesch,et al.  The human serotonin transporter gene polymorphism-basic research and clinical implications , 2005, Journal of Neural Transmission.

[48]  Avshalom Caspi,et al.  Gene–environment interactions in psychiatry: joining forces with neuroscience , 2006, Nature Reviews Neuroscience.

[49]  P Riederer,et al.  Allelic Variation of Human Serotonin Transporter Gene Expression , 1996, Journal of neurochemistry.

[50]  M. Nöthen,et al.  Schizophrenia and the serotonin transporter gene , 1998, Psychiatric genetics.

[51]  Peter Zwanzger,et al.  Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. , 2004, Archives of general psychiatry.

[52]  P. F. M. Janssen,et al.  Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding , 1996, Psychopharmacology.

[53]  W. Riedel,et al.  Tryptophan modulation and cognition. , 2003, Advances in experimental medicine and biology.

[54]  B. Thelma,et al.  Molecular genetics of schizophrenia: past, present and future , 2002, Journal of Biosciences.

[55]  M. Nöthen,et al.  No association between serotonin transporter gene polymorphisms and personality traits. , 1999, American journal of medical genetics.

[56]  C. Benkelfat,et al.  A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders , 2003, Molecular Psychiatry.

[57]  R. Blakely,et al.  Alternative Splicing of the Human Serotonin Transporter Gene , 1997, Journal of neurochemistry.

[58]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[59]  B. Pollock,et al.  Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors. , 2001, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[60]  E. sanders-Bush,et al.  Serotonin and brain development. , 2004, International review of neurobiology.

[61]  M. First,et al.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. , 1992, Archives of general psychiatry.

[62]  B Müller-Oerlinghausen,et al.  Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia , 2001, Molecular Psychiatry.

[63]  C. Fiskerstrand,et al.  An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells , 1999, FEBS letters.

[64]  P. Riederer,et al.  Organization of the human serotonin transporter gene , 2005, Journal of Neural Transmission / General Section JNT.